本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sagimet Biosciences Inc.

10.46
0.0000
成交量:30.18萬
成交額:317.15萬
市值:6.50億
市盈率:-8.38
高:10.62
開:10.51
低:10.41
收:10.46
52周最高:11.45
52周最低:4.50
股本:6,215.87萬
流通股本:5,578.08萬
量比:0.46
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.2490
每股收益(LYR):-1.5800
淨資產收益率:-24.37%
總資產收益率:-16.41%
市淨率:2.54
市盈率(LYR):-6.62

資料載入中...

2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/24

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/22

重要事件披露

Form 8-K - Current report